Results 121 to 130 of about 47,275 (224)

Urolithin A has antiplatelet effects in contrast to its glucuronide, urolithin B, and isourolithin A. [PDF]

Front Cardiovasc Med
Soloviova A, Hrubša M, García CJ, Lomozová Z, Tomás-Barberán FA, Mladěnka P.   +5 more
europepmc   +1 more source

Modifiable Correlates With Systemic Thromboxane Generation and Association With Cardiovascular Outcomes: Results From the Framingham Heart Study. [PDF]

Arterioscler Thromb Vasc Biol
Qian F, Gajjar P, Prescott B, Mitchell GF, Xanthakis V, Rade JJ, Nayor M.   +6 more
europepmc   +1 more source

New trends in thromboxane and prostacyclin modulators

, 2000
Thromboxane A2 (TXA2) and prostacyclin (PGI2) are two labile products formed from arachidonic acid by the way of cyclooxygenase. An overproduction of thromboxane A2 has been detected in a series of diseases whereby this prostanoid is assumed to ...
Delarge, J, David, J L, de Leval, X, Masereel, B, Dogné, Jean-Michel   +4 more
core  

Platelet miR-144-5p regulates COX-1/2 expression and modulates aspirin response in patients with cardiometabolic risk. [PDF]

Blood Vessel Thromb Hemost
Simeone PG, Liani R, Abbonante V, Alfonsetti M, Frezza M, Lanuti P, Recchiuti A, Balduini A, Santilli F.   +8 more
europepmc   +1 more source

In Patients Experiencing Pain and Inflammation, the Use of Non-Steroidal Anti-Inflammatory Drugs Is More Likely a Marker of the Observed Cardiovascular Risk Rather than Its Cause: A Viewpoint. [PDF]

Pharmacy (Basel)
Zingler G, Herdegen T.
europepmc   +1 more source

Brain pro-resolving-to-pro-inflammatory lipids and cPLA₂ activation associations with late-life cognitive trajectories. [PDF]

EBioMedicine
Yaskolka Meir A, Wang X, Li B, Wilson RS, Bennett DA, Louie SG, Yassine HN, Arvanitakis Z.   +7 more
europepmc   +1 more source

New insights into flavonoid binding to the thromboxane A₂ receptor. [PDF]

Blood Vessel Thromb Hemost
Han C, Chu X, Ren P, Lonkar P, Bassot A, Cosset E, Xu B, Mammadova-Bach E, Gudermann T, Braun A.   +9 more
europepmc   +1 more source

Age-Related Platelet Cox-1 Upregulation in Atrial Fibrillation. [PDF]

Int J Mol Sci
Valeriani E, Cammisotto V, Menichelli D, Pastori D, Castellani V, Bartimoccia S, Cucchiara G, Pannunzio A, Palumbo IM, Martinelli O, Carnevale R, Violi F, Pignatelli P.   +12 more
europepmc   +1 more source

PCSK9 Inhibitor Attenuates Platelet TLR4 in ACS and TLR4 Blockers Prevent PCSK9-Mediated Platelet Activation. [PDF]

Acta Cardiol Sin
Qi L, Yuan M, Liu X, Liu T, Zhang Y, Chen K.   +5 more
europepmc   +1 more source

Body mass index adjusted aspirin dosing does not overcome pharmacokinetic and pharmacodynamic disadvantages in obese pregnant women at risk for preeclampsia: a prospective cohort study. [PDF]

Front Med (Lausanne)
Karaduman FS, Cim N, Caliskan M, Cim B, Ergani SY, Guleroglu FY, Cetin A.   +6 more
europepmc   +1 more source